Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Arbutus Biopharma Corp. buy Lutz69

Start price
€3.79
20.09.21 / 50%
Target price
-
20.09.25
Performance (%)
-26.16%
End price
€2.80
03.04.23
Summary
This prediction ended on 03.04.23 with a price of €2.80. The prediction for Arbutus Biopharma Corp. disappointed with a performance of -26.16%. Lutz69 has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Arbutus Biopharma Corp. -1.167% -1.167% 10.435%
iShares Core DAX® 1.051% -1.833% 12.822%
iShares Nasdaq 100 -0.547% -3.738% 40.625%
iShares Nikkei 225® -1.778% -8.115% 16.092%
iShares S&P 500 0.002% -2.226% 28.387%

According to Lutz69 what are the pros and cons of Arbutus Biopharma Corp. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by Lutz69 for this prediction

In the thread Arbutus Biopharma Corp. diskutieren

Buy Arbutus Biopharma Corp.

In the thread Trading Arbutus Biopharma Corp.
Prediction Buy
Perf. (%) -26.16%
Target price
Change
Ends at 20.09.25

Buy beendet

Stopped prediction by Lutz69 for Arbutus Biopharma Corp.

buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.80
03.04.23
-
03.04.27
-12.14%
11.03.24

Could be worthwhile Investment >10% per year